*Akanji AO et al. (2011) Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects. Clin Chem Lab Med. 49(10):1681-90 *Dowling P et al. (2014) Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease. BMC Genomics. 2014 Oct 17;15:904. doi: 10.1186/1471-2164-15-904*Cha J et al. (2015) Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice. Am J Cardiovasc Dis 2015;5(1):53-62*Millar JS et al. (2015) Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects. J Clin Invest. 125(6):2510-22*Rath MW et al. (2015) Transgenic mouse expressing human apo(a) and human apo(B-100) with disabled vitamin C gene produces human Lp(a).United States Patent Application 20150074837*Wu T et al. (2015) The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols. J Pharmacol Sci. 127(3):251-9. doi: 10.1016/j.jphs.2014.12.002. Epub 2014 Dec 15* Cha J et al. (2016) Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice. Int J Oncol. 49(3):895-902. Epub 2016 Jul 1.* Rath MW et al. (2016) Transgenic mouse expressing human lipoprotein (a) with disabled vitamin c gene and its use as a disease treatment model Patent application: WO2016057050 A1, PCT/US2014/060195 * Turker Y et al.(2016) High sensitive CRP and sICAM-1 can predict Major Adverse Cardiovascular Events: MELEN Study: A Large Turkish Population Based Study. Konuralp Tip Dergisi 2016;8(1):14-22 * Shi L et al. (2018) Cardiovascular Effects of Cyclical Dietary Vitamin C Withdrawal in Mice Deficient in Internal Synthesis Vitamin C and producing human lipoprotein (a): Gulo(-/-); Lp(a)+. Int J Cardiovasc Res 7:6